Patient characteristics
| . | Aggressive (N = 42) . | Indolent (N = 15) . | HL/T (N = 36) . | Total (N = 93) . |
|---|---|---|---|---|
| Age, y | ||||
| Median | 66.5 | 64.0 | 48.5 | 62.0 |
| Range | 44.0-91.0 | 45.0-83.0 | 18.0-84.0 | 18.0-91.0 |
| Sex, female, no. (%) | 18 (43) | 10 (67) | 14 (39) | 42 (45) |
| Performance score, no. (%) | ||||
| 0 | 12 (29) | 7 (47) | 13 (36) | 32 (34) |
| 1 | 26 (61) | 7 (47) | 14 (39) | 47 (51) |
| 2 | 4 (10) | 1 (6) | 9 (25) | 14 (15) |
| B-symptoms, no. (%) | 4 (10) | 3 (20) | 5 (14) | 12 (13) |
| Stage, no. (%) | ||||
| 1 | 0 (0) | 1 (7) | 2 (6) | 3 (3) |
| 2 | 9 (21) | 0 (0) | 4 (11) | 13 (14) |
| 3 | 7 (17) | 1 (7) | 3 (8) | 11 (12) |
| 4 | 26 (62) | 13 (87) | 27 (75) | 66 (71) |
| Extranodal site involvement, no. (%) | 27 (64) | 13 (87) | 29 (81) | 69 (74) |
| Current disease status, no. (%) | ||||
| Relapse | 34 (81) | 12 (80) | 32 (89) | 78 (84) |
| Refractory | 8 (19) | 3 (20) | 4 (11) | 15 (16) |
| Lymphoma type, no. (%) | ||||
| DLBCL | 37 (88) | — | — | 37 (40) |
| MCL | 4 (10) | — | — | 4 (4) |
| FL III | 1 (2) | — | — | 1 (1) |
| Chronic lymphocytic leukemia/small lymphocytic lymphoma | 5 (33) | — | 5 (5) | |
| Extranodal marginal zone B cell | — | 1 (7) | — | 1 (1) |
| Follicular grade I | — | 3 (20) | — | 3 (3) |
| Follicular grade II | — | 6 (40) | — | 6 (7) |
| HL | — | — | 19 (53) | 19 (20) |
| Mycosis fungoides | — | — | 4 (11) | 4 (4) |
| Peripheral T cell, unspecified | — | — | 8 (22) | 8 (9) |
| Anaplastic large cell, primary systemic | — | — | 2 (6) | 2 (2) |
| Anaplastic large cell, primary cutaneous | — | — | 3 (8) | 3 (3) |
| No. of prior treatments, no. (%) | ||||
| 1 | 2 (5) | 0 (0) | 1 (3) | 3 (3) |
| 2 | 6 (14) | 0 (0) | 2 (6) | 8 (9) |
| 3 | 7 (17) | 2 (13) | 4 (11) | 13 (14) |
| 4 | 4 (10) | 2 (13) | 11 (31) | 17 (18) |
| 5 | 6 (14) | 4 (27) | 4 (11) | 14 (15) |
| > 5 | 17 (40) | 7 (47) | 14 (39) | 41 (44) |
| Prior autologous stem transplant, no. (%) | 17 (41) | 3 (20) | 24 (67) | 44 (47) |
| Previous radiation therapy, no. (%) | 16 (38) | 4 (27) | 20 (56) | 40 (43) |
| . | Aggressive (N = 42) . | Indolent (N = 15) . | HL/T (N = 36) . | Total (N = 93) . |
|---|---|---|---|---|
| Age, y | ||||
| Median | 66.5 | 64.0 | 48.5 | 62.0 |
| Range | 44.0-91.0 | 45.0-83.0 | 18.0-84.0 | 18.0-91.0 |
| Sex, female, no. (%) | 18 (43) | 10 (67) | 14 (39) | 42 (45) |
| Performance score, no. (%) | ||||
| 0 | 12 (29) | 7 (47) | 13 (36) | 32 (34) |
| 1 | 26 (61) | 7 (47) | 14 (39) | 47 (51) |
| 2 | 4 (10) | 1 (6) | 9 (25) | 14 (15) |
| B-symptoms, no. (%) | 4 (10) | 3 (20) | 5 (14) | 12 (13) |
| Stage, no. (%) | ||||
| 1 | 0 (0) | 1 (7) | 2 (6) | 3 (3) |
| 2 | 9 (21) | 0 (0) | 4 (11) | 13 (14) |
| 3 | 7 (17) | 1 (7) | 3 (8) | 11 (12) |
| 4 | 26 (62) | 13 (87) | 27 (75) | 66 (71) |
| Extranodal site involvement, no. (%) | 27 (64) | 13 (87) | 29 (81) | 69 (74) |
| Current disease status, no. (%) | ||||
| Relapse | 34 (81) | 12 (80) | 32 (89) | 78 (84) |
| Refractory | 8 (19) | 3 (20) | 4 (11) | 15 (16) |
| Lymphoma type, no. (%) | ||||
| DLBCL | 37 (88) | — | — | 37 (40) |
| MCL | 4 (10) | — | — | 4 (4) |
| FL III | 1 (2) | — | — | 1 (1) |
| Chronic lymphocytic leukemia/small lymphocytic lymphoma | 5 (33) | — | 5 (5) | |
| Extranodal marginal zone B cell | — | 1 (7) | — | 1 (1) |
| Follicular grade I | — | 3 (20) | — | 3 (3) |
| Follicular grade II | — | 6 (40) | — | 6 (7) |
| HL | — | — | 19 (53) | 19 (20) |
| Mycosis fungoides | — | — | 4 (11) | 4 (4) |
| Peripheral T cell, unspecified | — | — | 8 (22) | 8 (9) |
| Anaplastic large cell, primary systemic | — | — | 2 (6) | 2 (2) |
| Anaplastic large cell, primary cutaneous | — | — | 3 (8) | 3 (3) |
| No. of prior treatments, no. (%) | ||||
| 1 | 2 (5) | 0 (0) | 1 (3) | 3 (3) |
| 2 | 6 (14) | 0 (0) | 2 (6) | 8 (9) |
| 3 | 7 (17) | 2 (13) | 4 (11) | 13 (14) |
| 4 | 4 (10) | 2 (13) | 11 (31) | 17 (18) |
| 5 | 6 (14) | 4 (27) | 4 (11) | 14 (15) |
| > 5 | 17 (40) | 7 (47) | 14 (39) | 41 (44) |
| Prior autologous stem transplant, no. (%) | 17 (41) | 3 (20) | 24 (67) | 44 (47) |
| Previous radiation therapy, no. (%) | 16 (38) | 4 (27) | 20 (56) | 40 (43) |
— indicates not applicable.